Ezatiostat (TER199 free base; TLK199) is a tripeptide analog of glutathione and is a selective and orally active glutathione S-transferase P1-1 (GSTP1) inhibitor. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation. Ezatiostat has the potential for myelodysplastic syndrome (MDS) treatment.
CAT No: HB00099
CAS No:168682-53-9
Synonyms/Alias:Ezatiostat;168682-53-9;Ezatiostat [INN];Terrapin 199;TLK-199;UNII-057D10I8S8;057D10I8S8;TLK199;Glycine, L-g-glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-,1,3-diethyl ester, (2R)-;ethyl (2S)-2-amino-5-[[(2R)-3-benzylsulfanyl-1-[[(1R)-2-ethoxy-2-oxo-1-phenylethyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoate;DTXSID40168592;gamma-Glutamyl-S-(benzyl)-cysteinyl-R(-)-phenylglycine diethyl ester;ezatiotsat;TER 199;TLK 199;ethyl (2S)-2-amino-4-{[(1R)-2-(benzylsulfanyl)-1-{[(1R)-2-ethoxy-2-oxo-1-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoate;Glycine, L-gamma-glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-, diethyl ester, (2R)-;Glycine, N-(N-L-gamma-glutamyl-S-(phenylmethyl)-L-cysteinyl)-D-2-phenyl-, diethyl ester;TLK 117;ETHYL (2R)-((4S)-4-AMINO-5-ETHOXY-5-OXOPENTANOYL)-S-BENZYL-L-CYSTEINYL-2-PHENYLGLYCINATE;Ethyl N5-((R)-3-(benzylthio)-1-(((R)-2-ethoxy-2-oxo-1-phenylethyl)amino)-1-oxopropan-2-yl)-L-glutaminate;GLYCINE, L-.GAMMA.-GLUTAMYL-S-(PHENYLMETHYL)-L-CYSTEINYL-2-PHENYL-, DIETHYL ESTER, (2R)-;T.199;ezatiostatum;ethyl (2S)-2-amino-4-(((1R)-2-(benzylsulfanyl)-1-(((1R)-2-ethoxy-2-oxo-1-phenylethyl)carbamoyl)ethyl)carbamoyl)butanoate;gamma-glutamyl-S-(benzyl)cysteinyl-phenylglycine diethyl ester;MFCD27982957;SCHEMBL420400;CHEMBL2110585;DTXCID8091083;EX-A345;HY-13634A;NSC758484;AKOS005266721;CS-1713;DB05460;NSC-758484;NCGC00263221-01;NCGC00263221-05;AS-74082;DA-63345;NS00072776;BRD-K98963219-001-01-2;Q27095680;(2R)-L-gamma-Glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-glycine Diethyl Ester; N-[N-L-gamma-Glutamyl-S-(phenylmethyl)-L-cysteinyl]-D-2-phenyl-glycine Diethyl Ester; Ter 199; Terrapin 199;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More